Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement

European Journal of Surgical Oncology

Volumn 32, Issue 5, 2006, Pages 498-501

  de Kanter, A Y ^a   Menke Pluijmers, M B E ^a   Henzen Logmans, S C ^a,c   van Geel, A N ^a   van Eijck, C J H ^a   Wiggers, T ^a,b   Eggermont, A M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Zuiderziekenhuis   (Netherlands)

Author keywords

Breast cancer; Extensive nodal involvement; Extra nodal growth; Failure; Sentinel node

Indexed keywords

DYE;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; AXILLA; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; ECHOGRAPHY; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOACTIVITY; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; COLORING AGENTS; DIAGNOSTIC ERRORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33646765411     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.02.012     Document Type: Article

References (22)

1. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
2. Krag D., Harlow S., Weaver D., and Ashikaga T. Technique of sentinel node resection in melanoma and breast cancer: probe-guided surgery and lymphatic mapping. Eur J Surg Oncol 24 (1998) 89-93
3. Reintgen D., Cruse C.W., Wells K., Berman C., Fenske N., Glass F., et al. The orderly progression of melanoma nodal metastases. Ann Surg 220 (1994) 759-767
4. Gershenwald J.E., Thompson W., Mansfield P.F., Lee J.E., Colome M.I., Tseng C.H., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 (1999) 976-983
5. Ross M.I., Reintgen D., and Balch C.M. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol 9 (1993) 219-223
6. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
7. Sener S.F., Winchester D.J., Brinkmann E., Winchester D.P., Alwawi E., Nickolov A., et al. Failure of sentinel lymph node mapping in patients with breast cancer. J Am Coll Surg 198 (2004) 732-736
8. Cox C.E., Dupont E., Whitehead G.F., Ebert M.D., Nguyen K., Peltz E.S., et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J 8 (2002) 88-91
9. Borgstein P.J., Pijpers R., Comans E.F., van Diest P.J., Boom R.P., and Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 186 (1998) 275-283
10. Schneebaum S., Stadler J., Cohen M., Yaniv D., Baron J., and Skornick Y. Gamma probe-guided sentinel node biopsy-optimal timing for injection. Eur J Surg Oncol 24 (1998) 515-519
11. Cox C.E., Pendas S., Cox J.M., Joseph E., Shons A.R., Yeatman T., et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227 (1998) 645-651 [discussion 651-3]
12. de Kanter A.Y., van Eijck C.H., van Geel A.N., Kruijt R.H., Henzen S.C., Paul M.A., et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86 (1999) 1459-1462
13. Tafra L., Lannin D.R., Swanson M.S., van Eyk J.J., Verbabac K.M., Chua A.N., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 (2001) 51-59
14. Sato K., Tamaki K., Shigekawa T., Tsude H., Kosuda S., Kusano S., et al. Clinicopathologic and technical factors associated with the uptake of radiocolloid by sentinel nodes in patients with breast cancer. Surg Today 33 (2003) 403-407
15. Krag D., Weaver D., Ashikaga T., Moffat F., Klimberg V.S., Shriver C., et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339 (1998) 941-946
16. O'Hea B.J., Hill A.D., El-Shirbiny A.M., Yeh S.D., Rosen P.P., Coit D.G., et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 186 (1998) 423-427
17. Roumen R.M., Valkenburg J.G., and Geuskens L.M. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 23 (1997) 495-502
18. Veronesi U., Paganelli G., Galimberti V., Viale G., Zurrida S., Bedoni M., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
19. Flett M.M., Going J.J., Stanton P.D., and Cooke T.G. Sentinel node localization in patients with breast cancer. Br J Surg 85 (1998) 991-993
20. Giuliano A.E., Jones R.C., Brennan M., and Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15 (1997) 2345-2350
21. Albertini J.J., Lyman G.H., Cox C., Yeatman T., Balducci L., Ku N., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama 276 (1996) 1818-1822
22. van der Ent F.W., Kengen R.A., van der Pol H.A., and Hoofwijk A.G. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 25 (1999) 24-29